Impact of environmental, social and governance agenda on tax
Andrew Howard, Ropes & Gray tax partner, addresses tax coming out of the shadows and becoming part of an environmental, social and governance (ESG) agenda.
Impact of tax reform on charitable giving
Cameron Casey, Ropes & Gray private client group partner, examines the various reforms included in the Tax Cuts and Jobs Act (TCJA) and how they may affect the federal tax benefits of charitable giving.
International trade developments
Ama Adams, Ropes & Gray litigation & enforcement partner, discusses the complex array of trade laws and regulations facing companies with international operations.
Anti-corruption & international risk developments
Alex Rene, co-chair of Ropes & Gray’s anti-corruption / international risk practice and managing partner of the firm’s Washington, D.C. office, discusses recent FCPA enforcement activity as well as international risks facing companies.
Cybersecurity in the investment management industry
Paulita Pike, Ropes & Gray investment management partner, addresses privacy and cybersecurity challenges facing the investment management industry.
Private equity investments
Neill Jakobe, Ropes & Gray private equity partner and managing partner of the firm’s Chicago office, discusses some of the key trends impacting private equity investments.
FTC's merger remedies study
Jonathan Klarfeld, Ropes & Gray antitrust partner, discusses key takeaways and likely impacts of the Federal Trade Commission's recent divestiture study.
Changing values of IP and data in deals
Ed Black, co-head of Ropes & Gray’s IP transactions and technology, media & telecommunications practice groups, discusses changing values of IP and data in M&A transactions.
UK corporate offence of failure to prevent tax evasion
Andrew Howard, Ropes & Gray tax partner, discusses the UK’s new corporate criminal offence of failure to prevent tax evasion, which goes into effect in September 2017.
EU excessive pricing laws
Ruchit Patel, Ropes & Gray antitrust partner, examines excessive pricing laws in the EU and the increase of cases involving generic pharmaceuticals.
Value-based health care: private equity investors
Deborah Gersh, Ropes & Gray health care partner, discusses considerations for private equity companies investing in the value-based health care space.
- Next Page